Titre : Infections à Paramyxoviridae

Infections à Paramyxoviridae : Questions médicales fréquentes

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une infection à Paramyxoviridae ?

Le diagnostic repose sur des tests sérologiques et des cultures virales.
Infections à Paramyxoviridae Diagnostic médical
#2

Quels tests sont utilisés pour confirmer une infection ?

Les tests PCR et les tests d'anticorps sont couramment utilisés.
Tests de diagnostic Infections à Paramyxoviridae
#3

Les symptômes aident-ils au diagnostic ?

Oui, les symptômes cliniques orientent souvent vers le diagnostic.
Symptômes Infections à Paramyxoviridae
#4

Peut-on diagnostiquer sans tests de laboratoire ?

Un diagnostic clinique peut être posé, mais les tests confirment l'infection.
Diagnostic médical Infections à Paramyxoviridae
#5

Les antécédents médicaux sont-ils importants ?

Oui, les antécédents d'exposition ou de vaccination sont cruciaux.
Antécédents médicaux Infections à Paramyxoviridae

Symptômes 5

#1

Quels sont les symptômes courants des infections ?

Fièvre, éruption cutanée, toux et douleurs musculaires sont fréquents.
Symptômes Infections à Paramyxoviridae
#2

Les infections à Paramyxoviridae causent-elles des complications ?

Oui, elles peuvent entraîner des complications comme la pneumonie.
Complications Infections à Paramyxoviridae
#3

Les symptômes varient-ils selon le virus ?

Oui, chaque virus de la famille peut provoquer des symptômes différents.
Variabilité des symptômes Infections à Paramyxoviridae
#4

Les symptômes apparaissent-ils rapidement ?

Les symptômes peuvent apparaître de quelques jours à quelques semaines après l'infection.
Temps d'incubation Infections à Paramyxoviridae
#5

Y a-t-il des symptômes spécifiques aux oreillons ?

Oui, les oreillons se manifestent par un gonflement des glandes salivaires.
Oreillons Infections à Paramyxoviridae

Prévention 5

#1

Comment prévenir les infections à Paramyxoviridae ?

La vaccination est la méthode la plus efficace pour prévenir ces infections.
Prévention Vaccins
#2

Les mesures d'hygiène sont-elles importantes ?

Oui, se laver les mains régulièrement aide à réduire le risque d'infection.
Hygiène Infections à Paramyxoviridae
#3

Les voyages augmentent-ils le risque d'infection ?

Oui, voyager dans des zones où les infections sont endémiques augmente le risque.
Voyages Infections à Paramyxoviridae
#4

Les enfants doivent-ils être vaccinés ?

Oui, la vaccination des enfants est essentielle pour prévenir les infections.
Vaccination Infections à Paramyxoviridae
#5

Les contacts avec des malades doivent-ils être évités ?

Oui, éviter les contacts avec des personnes infectées aide à prévenir la transmission.
Transmission Infections à Paramyxoviridae

Traitements 5

#1

Quel est le traitement principal des infections ?

Il n'existe pas de traitement antiviral spécifique, le traitement est symptomatique.
Traitement Infections à Paramyxoviridae
#2

Les antibiotiques sont-ils efficaces contre ces infections ?

Non, les antibiotiques ne sont pas efficaces contre les infections virales.
Antibiotiques Infections à Paramyxoviridae
#3

Comment soulager les symptômes ?

Des antipyrétiques et des analgésiques peuvent aider à soulager la fièvre et la douleur.
Symptômes Traitement
#4

Les vaccins sont-ils disponibles ?

Oui, des vaccins existent pour prévenir certaines infections comme la rougeole.
Vaccins Infections à Paramyxoviridae
#5

Quand consulter un médecin pour ces infections ?

Consultez un médecin si les symptômes s'aggravent ou persistent.
Consultation médicale Infections à Paramyxoviridae

Complications 5

#1

Quelles sont les complications possibles des infections ?

Les complications incluent la pneumonie, l'encéphalite et la méningite.
Complications Infections à Paramyxoviridae
#2

Les complications sont-elles fréquentes ?

Elles sont rares mais peuvent survenir, surtout chez les personnes immunodéprimées.
Immunodépression Infections à Paramyxoviridae
#3

Comment prévenir les complications ?

La vaccination et un suivi médical régulier aident à prévenir les complications.
Prévention Complications
#4

Les complications peuvent-elles être graves ?

Oui, certaines complications peuvent être graves et nécessiter une hospitalisation.
Gravité Infections à Paramyxoviridae
#5

Les complications affectent-elles tous les âges ?

Elles peuvent affecter tous les âges, mais les jeunes enfants sont plus à risque.
Âge Infections à Paramyxoviridae

Facteurs de risque 5

#1

Quels sont les principaux facteurs de risque ?

Les facteurs incluent l'âge, l'immunodépression et le statut vaccinal.
Facteurs de risque Infections à Paramyxoviridae
#2

Les personnes non vaccinées sont-elles plus à risque ?

Oui, les personnes non vaccinées sont à risque accru d'infection.
Vaccination Infections à Paramyxoviridae
#3

Les voyages à l'étranger augmentent-ils le risque ?

Oui, voyager dans des régions où les infections sont courantes augmente le risque.
Voyages Infections à Paramyxoviridae
#4

Les enfants sont-ils plus vulnérables ?

Oui, les enfants, surtout ceux non vaccinés, sont plus vulnérables aux infections.
Enfants Infections à Paramyxoviridae
#5

Les personnes âgées sont-elles à risque ?

Oui, les personnes âgées peuvent également être à risque, surtout si immunodéprimées.
Personnes âgées Infections à Paramyxoviridae
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Infections à Paramyxoviridae : Questions médicales les plus fréquentes", "headline": "Infections à Paramyxoviridae : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Infections à Paramyxoviridae : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-04-05", "dateModified": "2026-03-26", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Infections à Paramyxoviridae" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Infections à Mononegavirales", "url": "https://questionsmedicales.fr/mesh/D018701", "about": { "@type": "MedicalCondition", "name": "Infections à Mononegavirales", "code": { "@type": "MedicalCode", "code": "D018701", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.925.782.580" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Infections à avulavirus", "alternateName": "Avulavirus Infections", "url": "https://questionsmedicales.fr/mesh/D045463", "about": { "@type": "MedicalCondition", "name": "Infections à avulavirus", "code": { "@type": "MedicalCode", "code": "D045463", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.925.782.580.600.080" } } }, { "@type": "MedicalWebPage", "name": "Infections à hénipavirus", "alternateName": "Henipavirus Infections", "url": "https://questionsmedicales.fr/mesh/D045464", "about": { "@type": "MedicalCondition", "name": "Infections à hénipavirus", "code": { "@type": "MedicalCode", "code": "D045464", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.925.782.580.600.400" } } }, { "@type": "MedicalWebPage", "name": "Infections à virus morbilleux", "alternateName": "Morbillivirus Infections", "url": "https://questionsmedicales.fr/mesh/D018185", "about": { "@type": "MedicalCondition", "name": "Infections à virus morbilleux", "code": { "@type": "MedicalCode", "code": "D018185", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.925.782.580.600.500" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Rougeole", "alternateName": "Measles", "url": "https://questionsmedicales.fr/mesh/D008457", "about": { "@type": "MedicalCondition", "name": "Rougeole", "code": { "@type": "MedicalCode", "code": "D008457", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.925.782.580.600.500.500" } } } ] }, { "@type": "MedicalWebPage", "name": "Infections à pneumovirus", "alternateName": "Pneumovirus Infections", "url": "https://questionsmedicales.fr/mesh/D018186", "about": { "@type": "MedicalCondition", "name": "Infections à pneumovirus", "code": { "@type": "MedicalCode", "code": "D018186", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.925.782.580.600.550" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Infections à virus respiratoire syncytial", "alternateName": "Respiratory Syncytial Virus Infections", "url": "https://questionsmedicales.fr/mesh/D018357", "about": { "@type": "MedicalCondition", "name": "Infections à virus respiratoire syncytial", "code": { "@type": "MedicalCode", "code": "D018357", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.925.782.580.600.550.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Infections à respirovirus", "alternateName": "Respirovirus Infections", "url": "https://questionsmedicales.fr/mesh/D010253", "about": { "@type": "MedicalCondition", "name": "Infections à respirovirus", "code": { "@type": "MedicalCode", "code": "D010253", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.925.782.580.600.600" } } }, { "@type": "MedicalWebPage", "name": "Infections à rubulavirus", "alternateName": "Rubulavirus Infections", "url": "https://questionsmedicales.fr/mesh/D019351", "about": { "@type": "MedicalCondition", "name": "Infections à rubulavirus", "code": { "@type": "MedicalCode", "code": "D019351", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C01.925.782.580.600.680" } } } ], "about": { "@type": "MedicalCondition", "name": "Infections à Paramyxoviridae", "alternateName": "Paramyxoviridae Infections", "code": { "@type": "MedicalCode", "code": "D018184", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "D V Erokhov", "url": "https://questionsmedicales.fr/author/D%20V%20Erokhov", "affiliation": { "@type": "Organization", "name": "Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing." } }, { "@type": "Person", "name": "P E Zherdeva", "url": "https://questionsmedicales.fr/author/P%20E%20Zherdeva", "affiliation": { "@type": "Organization", "name": "Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing." } }, { "@type": "Person", "name": "N T Tikhonova", "url": "https://questionsmedicales.fr/author/N%20T%20Tikhonova", "affiliation": { "@type": "Organization", "name": "Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing." } }, { "@type": "Person", "name": "T S Rubalskaia", "url": "https://questionsmedicales.fr/author/T%20S%20Rubalskaia", "affiliation": { "@type": "Organization", "name": "Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing." } }, { "@type": "Person", "name": "Gaojian Li", "url": "https://questionsmedicales.fr/author/Gaojian%20Li", "affiliation": { "@type": "Organization", "name": "National Research Center for Wildlife-Borne Diseases, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Burden of human metapneumovirus infections among children with acute respiratory tract infections attending a Tertiary Care Hospital, Kathmandu.", "datePublished": "2023-08-07", "url": "https://questionsmedicales.fr/article/37550689", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12887-023-04208-6" } }, { "@type": "ScholarlyArticle", "name": "Global genetic diversity of measles virus (Paramyxoviridae:", "datePublished": "2023-11-07", "url": "https://questionsmedicales.fr/article/38156571", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.36233/0507-4088-187" } }, { "@type": "ScholarlyArticle", "name": "Molecular detection and genotyping of HMPV in patients with severe acute respiratory infection in India.", "datePublished": "2024-09-02", "url": "https://questionsmedicales.fr/article/39221771", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1080/07853890.2024.2398719" } }, { "@type": "ScholarlyArticle", "name": "Epidemiology and clinical severity of the serotypes of human parainfluenza virus in children with acute respiratory infection.", "datePublished": "2023-10-26", "url": "https://questionsmedicales.fr/article/37885007", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12985-023-02214-9" } }, { "@type": "ScholarlyArticle", "name": "Clinical and epidemiological characteristics of 96 pediatric human metapneumovirus infections in Henan, China after COVID-19 pandemic: a retrospective analysis.", "datePublished": "2024-04-30", "url": "https://questionsmedicales.fr/article/38689312", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s12985-024-02376-0" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Infection", "item": "https://questionsmedicales.fr/mesh/D007239" }, { "@type": "ListItem", "position": 3, "name": "Maladies virales", "item": "https://questionsmedicales.fr/mesh/D014777" }, { "@type": "ListItem", "position": 4, "name": "Infections à virus à ARN", "item": "https://questionsmedicales.fr/mesh/D012327" }, { "@type": "ListItem", "position": 5, "name": "Infections à Mononegavirales", "item": "https://questionsmedicales.fr/mesh/D018701" }, { "@type": "ListItem", "position": 6, "name": "Infections à Paramyxoviridae", "item": "https://questionsmedicales.fr/mesh/D018184" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Infections à Paramyxoviridae - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Infections à Paramyxoviridae", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2026-05-06", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Infections à Paramyxoviridae", "description": "Comment diagnostiquer une infection à Paramyxoviridae ?\nQuels tests sont utilisés pour confirmer une infection ?\nLes symptômes aident-ils au diagnostic ?\nPeut-on diagnostiquer sans tests de laboratoire ?\nLes antécédents médicaux sont-ils importants ?", "url": "https://questionsmedicales.fr/mesh/D018184#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Infections à Paramyxoviridae", "description": "Quels sont les symptômes courants des infections ?\nLes infections à Paramyxoviridae causent-elles des complications ?\nLes symptômes varient-ils selon le virus ?\nLes symptômes apparaissent-ils rapidement ?\nY a-t-il des symptômes spécifiques aux oreillons ?", "url": "https://questionsmedicales.fr/mesh/D018184#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Infections à Paramyxoviridae", "description": "Comment prévenir les infections à Paramyxoviridae ?\nLes mesures d'hygiène sont-elles importantes ?\nLes voyages augmentent-ils le risque d'infection ?\nLes enfants doivent-ils être vaccinés ?\nLes contacts avec des malades doivent-ils être évités ?", "url": "https://questionsmedicales.fr/mesh/D018184#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Infections à Paramyxoviridae", "description": "Quel est le traitement principal des infections ?\nLes antibiotiques sont-ils efficaces contre ces infections ?\nComment soulager les symptômes ?\nLes vaccins sont-ils disponibles ?\nQuand consulter un médecin pour ces infections ?", "url": "https://questionsmedicales.fr/mesh/D018184#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Infections à Paramyxoviridae", "description": "Quelles sont les complications possibles des infections ?\nLes complications sont-elles fréquentes ?\nComment prévenir les complications ?\nLes complications peuvent-elles être graves ?\nLes complications affectent-elles tous les âges ?", "url": "https://questionsmedicales.fr/mesh/D018184#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Infections à Paramyxoviridae", "description": "Quels sont les principaux facteurs de risque ?\nLes personnes non vaccinées sont-elles plus à risque ?\nLes voyages à l'étranger augmentent-ils le risque ?\nLes enfants sont-ils plus vulnérables ?\nLes personnes âgées sont-elles à risque ?", "url": "https://questionsmedicales.fr/mesh/D018184#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection à Paramyxoviridae ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des tests sérologiques et des cultures virales." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour confirmer une infection ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Les tests PCR et les tests d'anticorps sont couramment utilisés." } }, { "@type": "Question", "name": "Les symptômes aident-ils au diagnostic ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes cliniques orientent souvent vers le diagnostic." } }, { "@type": "Question", "name": "Peut-on diagnostiquer sans tests de laboratoire ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Un diagnostic clinique peut être posé, mais les tests confirment l'infection." } }, { "@type": "Question", "name": "Les antécédents médicaux sont-ils importants ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les antécédents d'exposition ou de vaccination sont cruciaux." } }, { "@type": "Question", "name": "Quels sont les symptômes courants des infections ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Fièvre, éruption cutanée, toux et douleurs musculaires sont fréquents." } }, { "@type": "Question", "name": "Les infections à Paramyxoviridae causent-elles des complications ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent entraîner des complications comme la pneumonie." } }, { "@type": "Question", "name": "Les symptômes varient-ils selon le virus ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, chaque virus de la famille peut provoquer des symptômes différents." } }, { "@type": "Question", "name": "Les symptômes apparaissent-ils rapidement ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent apparaître de quelques jours à quelques semaines après l'infection." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques aux oreillons ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les oreillons se manifestent par un gonflement des glandes salivaires." } }, { "@type": "Question", "name": "Comment prévenir les infections à Paramyxoviridae ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination est la méthode la plus efficace pour prévenir ces infections." } }, { "@type": "Question", "name": "Les mesures d'hygiène sont-elles importantes ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, se laver les mains régulièrement aide à réduire le risque d'infection." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque d'infection ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones où les infections sont endémiques augmente le risque." } }, { "@type": "Question", "name": "Les enfants doivent-ils être vaccinés ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la vaccination des enfants est essentielle pour prévenir les infections." } }, { "@type": "Question", "name": "Les contacts avec des malades doivent-ils être évités ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, éviter les contacts avec des personnes infectées aide à prévenir la transmission." } }, { "@type": "Question", "name": "Quel est le traitement principal des infections ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Il n'existe pas de traitement antiviral spécifique, le traitement est symptomatique." } }, { "@type": "Question", "name": "Les antibiotiques sont-ils efficaces contre ces infections ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Non, les antibiotiques ne sont pas efficaces contre les infections virales." } }, { "@type": "Question", "name": "Comment soulager les symptômes ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Des antipyrétiques et des analgésiques peuvent aider à soulager la fièvre et la douleur." } }, { "@type": "Question", "name": "Les vaccins sont-ils disponibles ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des vaccins existent pour prévenir certaines infections comme la rougeole." } }, { "@type": "Question", "name": "Quand consulter un médecin pour ces infections ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Consultez un médecin si les symptômes s'aggravent ou persistent." } }, { "@type": "Question", "name": "Quelles sont les complications possibles des infections ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la pneumonie, l'encéphalite et la méningite." } }, { "@type": "Question", "name": "Les complications sont-elles fréquentes ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Elles sont rares mais peuvent survenir, surtout chez les personnes immunodéprimées." } }, { "@type": "Question", "name": "Comment prévenir les complications ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "La vaccination et un suivi médical régulier aident à prévenir les complications." } }, { "@type": "Question", "name": "Les complications peuvent-elles être graves ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certaines complications peuvent être graves et nécessiter une hospitalisation." } }, { "@type": "Question", "name": "Les complications affectent-elles tous les âges ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Elles peuvent affecter tous les âges, mais les jeunes enfants sont plus à risque." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent l'âge, l'immunodépression et le statut vaccinal." } }, { "@type": "Question", "name": "Les personnes non vaccinées sont-elles plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes non vaccinées sont à risque accru d'infection." } }, { "@type": "Question", "name": "Les voyages à l'étranger augmentent-ils le risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des régions où les infections sont courantes augmente le risque." } }, { "@type": "Question", "name": "Les enfants sont-ils plus vulnérables ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les enfants, surtout ceux non vaccinés, sont plus vulnérables aux infections." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles à risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées peuvent également être à risque, surtout si immunodéprimées." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 26/03/2026

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

D V Erokhov

3 publications dans cette catégorie

Affiliations :
  • Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing.
Publications dans "Infections à Paramyxoviridae" :

P E Zherdeva

3 publications dans cette catégorie

Affiliations :
  • Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing.
Publications dans "Infections à Paramyxoviridae" :

N T Tikhonova

3 publications dans cette catégorie

Affiliations :
  • Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing.
Publications dans "Infections à Paramyxoviridae" :

T S Rubalskaia

2 publications dans cette catégorie

Affiliations :
  • Gabrichevsky Moscow Research Institute of Epidemiology and Microbiology Federal Service for Surveillance on Consumer Rights Protection and Human Wellbeing.
Publications dans "Infections à Paramyxoviridae" :

Gaojian Li

2 publications dans cette catégorie

Affiliations :
  • National Research Center for Wildlife-Borne Diseases, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
  • University of Chinese Academy of Sciences, Beijing 100101, China.
Publications dans "Infections à Paramyxoviridae" :

Tao Zhang

2 publications dans cette catégorie

Affiliations :
  • National Research Center for Wildlife-Borne Diseases, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Publications dans "Infections à Paramyxoviridae" :

Bin Hu

2 publications dans cette catégorie

Affiliations :
  • National Research Center for Wildlife-Borne Diseases, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
  • University of Chinese Academy of Sciences, Beijing 100101, China.
Publications dans "Infections à Paramyxoviridae" :

Shuyi Han

2 publications dans cette catégorie

Affiliations :
  • National Research Center for Wildlife-Borne Diseases, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
  • University of Chinese Academy of Sciences, Beijing 100101, China.
Publications dans "Infections à Paramyxoviridae" :

Chen Xiang

2 publications dans cette catégorie

Affiliations :
  • National Research Center for Wildlife-Borne Diseases, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
  • University of Chinese Academy of Sciences, Beijing 100101, China.
Publications dans "Infections à Paramyxoviridae" :

Guohui Yuan

2 publications dans cette catégorie

Affiliations :
  • National Research Center for Wildlife-Borne Diseases, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Publications dans "Infections à Paramyxoviridae" :

Hongxuan He

2 publications dans cette catégorie

Affiliations :
  • National Research Center for Wildlife-Borne Diseases, Institute of Zoology, Chinese Academy of Sciences, Beijing 100101, China.
Publications dans "Infections à Paramyxoviridae" :

None None

2 publications dans cette catégorie

Publications dans "Infections à Paramyxoviridae" :

Leah C Katzelnick

2 publications dans cette catégorie

Affiliations :
  • Viral Epidemiology and Immunity Unit, Laboratory of Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD, USA.

Guillermina Kuan

2 publications dans cette catégorie

Affiliations :
  • Sustainable Sciences Institute, Managua, Nicaragua.
  • Centro de Salud Sócrates Flores Vivas, Ministerio de Salud, Managua, Nicaragua.

Angel Balmaseda

2 publications dans cette catégorie

Affiliations :
  • Sustainable Sciences Institute, Managua, Nicaragua.
  • Laboratorio Nacional de Virología, Centro Nacional de Diagnóstico y Referencia, Ministerio de Salud, Managua, Nicaragua.

Eva Harris

2 publications dans cette catégorie

Affiliations :
  • Division of Infectious Diseases and Vaccinology, School of Public Health, University of California, Berkeley, Berkeley, CA, USA. eharris@berkeley.edu.

Hiam Chemaitelly

2 publications dans cette catégorie

Affiliations :
  • From the Infectious Disease Epidemiology Group and the World Health Organization Collaborating Center for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Education City (H.N.A., H.C., L.J.A.-R.), the Mathematics Program, Department of Mathematics, Statistics, and Physics, College of Arts and Sciences (H.H.A.), the Biomedical Research Center (H.M.Y., H.A.A.-K., M.K.S., P.C., G.K.N.), and the Departments of Biomedical Science (H.M.Y., H.A.A.-K., M.K.S., G.K.N.) and Public Health (H.F.A.-R., L.J.A.-R.), College of Health Sciences, QU Health, Qatar University, the Department of Pathology, Sidra Medicine (P.T., M.R.H.), Hamad Medical Corporation (P.C., Z.A.-K., E.A.-K., A.J., A.H.K., A.N.L., R.M.S., A.A.B., A.A.-K.), Primary Health Care Corporation (M.G.A.-K.), and the Ministry of Public Health (H.E.A.-R., M.H.A.-T., R.B.) - all in Doha, Qatar; the Departments of Population Health Sciences (H.N.A., H.C., A.A.B., L.J.A.-R.) and Medicine (A.A.B.), Weill Cornell Medicine, Cornell University, New York; and the Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, United Kingdom (P.C.).

Houssein H Ayoub

2 publications dans cette catégorie

Affiliations :
  • From the Infectious Disease Epidemiology Group and the World Health Organization Collaborating Center for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Education City (H.N.A., H.C., L.J.A.-R.), the Mathematics Program, Department of Mathematics, Statistics, and Physics, College of Arts and Sciences (H.H.A.), the Biomedical Research Center (H.M.Y., H.A.A.-K., M.K.S., P.C., G.K.N.), and the Departments of Biomedical Science (H.M.Y., H.A.A.-K., M.K.S., G.K.N.) and Public Health (H.F.A.-R., L.J.A.-R.), College of Health Sciences, QU Health, Qatar University, the Department of Pathology, Sidra Medicine (P.T., M.R.H.), Hamad Medical Corporation (P.C., Z.A.-K., E.A.-K., A.J., A.H.K., A.N.L., R.M.S., A.A.B., A.A.-K.), Primary Health Care Corporation (M.G.A.-K.), and the Ministry of Public Health (H.E.A.-R., M.H.A.-T., R.B.) - all in Doha, Qatar; the Departments of Population Health Sciences (H.N.A., H.C., A.A.B., L.J.A.-R.) and Medicine (A.A.B.), Weill Cornell Medicine, Cornell University, New York; and the Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, United Kingdom (P.C.).

Laith J Abu-Raddad

2 publications dans cette catégorie

Affiliations :
  • From the Infectious Disease Epidemiology Group and the World Health Organization Collaborating Center for Disease Epidemiology Analytics on HIV/AIDS, Sexually Transmitted Infections, and Viral Hepatitis, Weill Cornell Medicine-Qatar, Cornell University, Education City (H.N.A., H.C., L.J.A.-R.), the Mathematics Program, Department of Mathematics, Statistics, and Physics, College of Arts and Sciences (H.H.A.), the Biomedical Research Center (H.M.Y., H.A.A.-K., M.K.S., P.C., G.K.N.), and the Departments of Biomedical Science (H.M.Y., H.A.A.-K., M.K.S., G.K.N.) and Public Health (H.F.A.-R., L.J.A.-R.), College of Health Sciences, QU Health, Qatar University, the Department of Pathology, Sidra Medicine (P.T., M.R.H.), Hamad Medical Corporation (P.C., Z.A.-K., E.A.-K., A.J., A.H.K., A.N.L., R.M.S., A.A.B., A.A.-K.), Primary Health Care Corporation (M.G.A.-K.), and the Ministry of Public Health (H.E.A.-R., M.H.A.-T., R.B.) - all in Doha, Qatar; the Departments of Population Health Sciences (H.N.A., H.C., A.A.B., L.J.A.-R.) and Medicine (A.A.B.), Weill Cornell Medicine, Cornell University, New York; and the Wellcome-Wolfson Institute for Experimental Medicine, Queens University, Belfast, United Kingdom (P.C.).

A V Milikhina

1 publication dans cette catégorie

Affiliations :
  • Center for Hygiene and Epidemiology in the Republic of Dagestan.
Publications dans "Infections à Paramyxoviridae" :

Sources (10000 au total)

Burden of human metapneumovirus infections among children with acute respiratory tract infections attending a Tertiary Care Hospital, Kathmandu.

Acute respiratory infections (ARIs) are one of the most common causes of mortality and morbidity worldwide. Every year millions of children suffer from viral respiratory tract infections (RTIs) rangin... Therefore, the study was focused on HMPV infections and other potential viral etiologies or co-infections using multiplex PCR among children attending Kanti Children's Hospital and assessed the clinic... HMPV infection (13.3%) was the most predominant infection among the different viral infections in children with ARIs in Kanti Children's Hospital. The HMPV was more prevalent in the age group less tha... This study provides the baseline information on HMPV and associated co-infection with other respiratory viruses for the differential diagnosis based on molecular methods and also the comparison of cli...

Molecular detection and genotyping of HMPV in patients with severe acute respiratory infection in India.

Human metapneumovirus (HMPV) is a common respiratory pathogen that causes respiratory tract infections. In India, HMPV has been identified as one of the leading causes of morbidity and mortality in in... A retrospective study was conducted to determine the circulating genotypes of HMPV among SARI cases from January 2016 to December 2018.... Positive throat swab samples were confirmed with real-time RT-PCR. Subsequently, these samples were analysed using semi-nested conventional RT-PCR targeting the G gene, followed by sequencing and phyl... All 20 samples from the SARI cases were classified under the A2c sublineage of HMPV. Phylogenetic analysis indicated that these strains were genetically related to those circulating in Japan, China, a... Clinical analysis showed that four cases had coinfections with other pathogens. Our extensive analysis of patient samples determined that HMPV, especially the A2c genotype, significantly contributed t...

Epidemiology and clinical severity of the serotypes of human parainfluenza virus in children with acute respiratory infection.

Acute respiratory infections (ARI) are a threat to human health and survival, resulting in many paediatric hospitalisations. However, the epidemiological and clinical severity characteristics of the h... To identify the epidemiological features of PIV infection, in 2019, hospitalised children with ARI were screened using multiplex polymerase chain reaction (PCR) for PIV and 10 other common respiratory... The annual detection rate for PIV was 14.9%, with a peak from April to September. Children under one year of age had the highest rate of PIV infection (45.5%) compared to other age groups. Of the 121 ... Here, PIV was the main pathogen causing ARI in hospitalised children. Appropriate attention should be paid to children with underlying diseases and co-infections to prevent the worsening of severe PIV...

Clinical and epidemiological characteristics of 96 pediatric human metapneumovirus infections in Henan, China after COVID-19 pandemic: a retrospective analysis.

In the aftermath of the COVID-19 pandemic, there has been a surge in human metapneumovirus (HMPV) transmission, surpassing pre-epidemic levels. We aim to elucidate the clinical and epidemiological cha... In this retrospective single-center study, participants diagnosed with laboratory confirmed HMPV infection through Targeted Next Generation Sequencing were included. The study encompassed individuals ... Between April 29 and June 5, 2023, 96 pediatric patients were identified as infected with HMPV with a median age of 33.5 months (interquartile range, 12 ~ 48 months). The majority (87.5%) of infected ... Our data systemically elucidated the clinical and epidemiological characteristics of pediatric patients with HMPV infection, which might be instructive to policy development for the prevention and con...

Epidemiology, genetic characteristics, and association with meteorological factors of human metapneumovirus infection in children in southern China: A 10-year retrospective study.

This study aimed to determine the epidemiological and genetic features of human metapneumovirus (HMPV) infection in children in southern China, and the effect of meteorological factors on infection.... 14,817 children (≤14 years) with acute respiratory tract infections from 2010 to 2019 were examined for HMPV and other respiratory viruses by real-time quantitative polymerase chain reaction. Full-len... HMPV was detected in 524 (3.5%) children, who were mostly younger than 1 year. The seasonal peak of HMPV prevalence mainly occurred in spring. Respiratory syncytial virus was the most common virus coi... HMPV is an important respiratory pathogen that causes acute respiratory tract infections in children in southern China, particularly in children ≤5 years old. The prevalence peak of HMPV in this area ...

Changes in the epidemiological patterns of respiratory syncytial virus and human metapneumovirus infection among pediatric patients and their correlation with severe cases: a long-term retrospective study.

We aim to investigate the prevalence of respiratory syncytial virus (RSV) and human metapneumovirus (hMPV) among pediatric patients with acute respiratory tract illness (ARTI) in southern China both p... The study conducted a real-time PCR analysis on hospitalized children with ARTI from 2012 to 2023, specifically targeting RSV, hMPV, and other respiratory pathogens. Additionally, demographic data was... The prevalence of RSV occurs triennially, and likewise, the temporal pattern of hMPV outbreaks mirrors that of RSV. The peak infection rates of RSV and hMPV occurred during and following the implement... The changing epidemiological patterns have the potential to lead to widespread severe outbreaks among children, particularly those with underlying medical conditions who may experience more severe sym...

Comparison of respiratory pathogens in children with community-acquired pneumonia before and during the COVID-19 pandemic.

Multifaceted non-pharmaceutical interventions during the COVID-19 pandemic have not only reduced the transmission of SARS-CoV2, but have had an effect on the prevalence of other pathogens. This retros... From January 2019 to December 2020, children with community-acquired pneumonia were selected from the Department of Respiratory Medicine, Shanghai Children's Medical Center. On the first day of hospit... A total of 2596 children with community-acquired pneumonia were enrolled, including 1871 patients in 2019 and 725 in 2020. The detection rate in 2020 was lower than in 2019, whether single or multiple... Strict public health interventions for COVID-19 in China have effectively suppressed the spread of not only SARS-CoV2 but parainfluenza virus, influenza virus and Mycoplasma pneumonia as well. However...

A surge in human metapneumovirus paediatric respiratory admissions in Western Australia following the reduction of SARS-CoV-2 non-pharmaceutical interventions.

Western Australian laboratory data demonstrated a decrease in human metapneumovirus (hMPV) detections through 2020 associated with SARS-CoV-2-related non-pharmaceutical interventions (NPIs), followed ... All respiratory-coded admissions of children aged <16 years at a tertiary paediatric centre between 2017 and 2021 were matched with respiratory virus testing data. Patients were grouped by age at pres... hMPV-positive admissions in 2021 were more than 2.8 times baseline. The largest increase in incidence was observed in the 1-4 years group (incidence rate ratio (IRR) 3.8; 95% confidence interval (CI):... The absence and subsequent surge underline the susceptibility of hMPV to NPIs. Increased hMPV-positive admissions in 2021 can be partially attributable to testing, but test-positivity remained high, c...